nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.0216	0.022	CbGpPWpGaD
Acebutolol—ADRB1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0188	0.0192	CbGpPWpGaD
Acebutolol—ADRB1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0185	0.0188	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0184	0.0188	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0181	0.0184	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0158	0.0161	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0155	0.0158	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0155	0.0158	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0152	0.0155	CbGpPWpGaD
Acebutolol—SLC22A1—Norepinephrine Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.015	0.0153	CbGpPWpGaD
Acebutolol—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—attention deficit hyperactivity disorder	0.0128	0.013	CbGpPWpGaD
Acebutolol—Pindolol—HTR1B—attention deficit hyperactivity disorder	0.0126	0.647	CrCbGaD
Acebutolol—SLC22A1—Norepinephrine Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.0113	0.0115	CbGpPWpGaD
Acebutolol—ADRB1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0112	0.0114	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0109	0.0112	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0108	0.011	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0105	0.0107	CbGpPWpGaD
Acebutolol—ADRB1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0104	0.0106	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0102	0.0104	CbGpPWpGaD
Acebutolol—ADRB1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0101	0.0103	CbGpPWpGaD
Acebutolol—ADRB1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0099	0.0101	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.00985	0.01	CbGpPWpGaD
Acebutolol—ADRB1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00977	0.00997	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00968	0.00987	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00956	0.00975	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0094	0.00959	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00919	0.00938	CbGpPWpGaD
Acebutolol—ADRB1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0091	0.00929	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00891	0.00908	CbGpPWpGaD
Acebutolol—SLC22A1—Amine compound SLC transporters—SLC6A3—attention deficit hyperactivity disorder	0.00887	0.00904	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00874	0.00891	CbGpPWpGaD
Acebutolol—ADRB1—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00867	0.00885	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00855	0.00872	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00846	0.00863	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00832	0.00848	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00828	0.00844	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00822	0.00838	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00814	0.0083	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00804	0.0082	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00765	0.00781	CbGpPWpGaD
Acebutolol—SLC22A1—Neurotransmitter Release Cycle—SNAP25—attention deficit hyperactivity disorder	0.0076	0.00775	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00749	0.00764	CbGpPWpGaD
Acebutolol—Propranolol—HTR1B—attention deficit hyperactivity disorder	0.00688	0.353	CrCbGaD
Acebutolol—ADRB1—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.0064	0.00653	CbGpPWpGaD
Acebutolol—ADRB1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00638	0.0065	CbGpPWpGaD
Acebutolol—ADRB2—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.00626	0.00639	CbGpPWpGaD
Acebutolol—ADRB2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00624	0.00636	CbGpPWpGaD
Acebutolol—SLC22A1—Neurotransmitter Release Cycle—MAOA—attention deficit hyperactivity disorder	0.00572	0.00583	CbGpPWpGaD
Acebutolol—ADRB1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00536	0.00547	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00533	0.00544	CbGpPWpGaD
Acebutolol—ADRB2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00524	0.00535	CbGpPWpGaD
Acebutolol—SLC22A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00453	0.00462	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00437	0.00446	CbGpPWpGaD
Acebutolol—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00425	0.00433	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00425	0.00433	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00408	0.00416	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00364	0.00371	CbGpPWpGaD
Acebutolol—ADRB1—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.0036	0.00368	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00356	0.00363	CbGpPWpGaD
Acebutolol—ADRB1—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00356	0.00363	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00356	0.00363	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00354	0.00361	CbGpPWpGaD
Acebutolol—ADRB2—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00353	0.0036	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00348	0.00355	CbGpPWpGaD
Acebutolol—ADRB2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00348	0.00355	CbGpPWpGaD
Acebutolol—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00347	0.00354	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00346	0.00353	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00311	0.00318	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00305	0.00311	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00305	0.00311	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00298	0.00304	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00277	0.00283	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00273	0.00278	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00247	0.00252	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00241	0.00246	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00237	0.00242	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00235	0.00239	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00232	0.00237	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00232	0.00237	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.0023	0.00235	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00227	0.00232	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0022	0.00224	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00218	0.00222	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00216	0.0022	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00211	0.00216	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00211	0.00215	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00209	0.00213	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00207	0.00211	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00201	0.00205	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.002	0.00204	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00196	0.002	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00195	0.00199	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00194	0.00198	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00194	0.00198	CbGpPWpGaD
Acebutolol—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00193	0.00196	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00191	0.00195	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.0019	0.00194	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00189	0.00192	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00187	0.00191	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00185	0.00189	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00184	0.00188	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00181	0.00185	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00181	0.00184	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.0018	0.00183	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00178	0.00181	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00176	0.00179	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00172	0.00175	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00172	0.00175	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00168	0.00171	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00167	0.0017	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00166	0.0017	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00165	0.00169	CbGpPWpGaD
Acebutolol—SLC22A1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00164	0.00167	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00164	0.00167	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00163	0.00166	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00162	0.00165	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00161	0.00164	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.0016	0.00163	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00158	0.00161	CbGpPWpGaD
Acebutolol—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00158	0.00161	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00158	0.00161	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00151	0.00154	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00149	0.00152	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00147	0.0015	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00141	0.00144	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00138	0.0014	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00135	0.00138	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00134	0.00137	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00131	0.00134	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00131	0.00134	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00131	0.00133	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00129	0.00131	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00128	0.00131	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00128	0.00131	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00127	0.00129	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00127	0.00129	CbGpPWpGaD
Acebutolol—SLC22A1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00126	0.00128	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00125	0.00127	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00124	0.00126	CbGpPWpGaD
Acebutolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00123	0.00125	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00123	0.00125	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00122	0.00124	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00122	0.00124	CbGpPWpGaD
Acebutolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.0012	0.00123	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0012	0.00123	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00119	0.00122	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00119	0.00121	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00117	0.00119	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00115	0.00117	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00112	0.00114	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00107	0.00109	CbGpPWpGaD
Acebutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00105	0.00108	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00105	0.00107	CbGpPWpGaD
Acebutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00103	0.00105	CbGpPWpGaD
Acebutolol—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00103	0.00105	CbGpPWpGaD
Acebutolol—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00102	0.00104	CbGpPWpGaD
Acebutolol—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00102	0.00104	CbGpPWpGaD
Acebutolol—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00101	0.00103	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000963	0.000982	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00091	0.000928	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00089	0.000908	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000837	0.000854	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000827	0.000843	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000819	0.000835	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000809	0.000825	CbGpPWpGaD
Acebutolol—ADRB1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000803	0.000819	CbGpPWpGaD
Acebutolol—SLC22A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000801	0.000817	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000796	0.000811	CbGpPWpGaD
Acebutolol—ADRB2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000785	0.000801	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000778	0.000794	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000763	0.000778	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00074	0.000754	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000723	0.000738	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000722	0.000737	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000719	0.000733	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000716	0.000731	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000707	0.000721	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000704	0.000718	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000704	0.000718	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000703	0.000717	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000701	0.000715	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000695	0.000709	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000691	0.000705	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000689	0.000703	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000689	0.000702	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00068	0.000694	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000676	0.000689	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000672	0.000685	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000657	0.00067	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00065	0.000663	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000648	0.000661	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000639	0.000652	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000636	0.000649	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000634	0.000646	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000631	0.000644	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000625	0.000638	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000618	0.00063	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000588	0.0006	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000575	0.000587	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000526	0.000537	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000526	0.000537	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000518	0.000528	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000488	0.000498	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000481	0.000491	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000478	0.000487	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000469	0.000479	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000454	0.000463	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000447	0.000456	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000444	0.000453	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000431	0.00044	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000427	0.000435	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000421	0.00043	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000421	0.000429	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000417	0.000426	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000412	0.00042	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000403	0.000411	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000401	0.000409	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000397	0.000405	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000388	0.000396	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000384	0.000392	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000378	0.000385	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000376	0.000383	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000373	0.00038	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000369	0.000377	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000365	0.000372	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000348	0.000354	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00034	0.000347	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000319	0.000325	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000317	0.000323	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000309	0.000315	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000309	0.000315	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000304	0.00031	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000291	0.000297	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000291	0.000297	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000286	0.000292	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000282	0.000288	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000266	0.000271	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000247	0.000252	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000243	0.000248	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000238	0.000243	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000235	0.000239	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000232	0.000237	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000221	0.000226	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000187	0.000191	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000186	0.000189	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000176	0.00018	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000175	0.000178	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000137	0.000139	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000129	0.000132	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000126	0.000129	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	8.02e-05	8.18e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	7.55e-05	7.7e-05	CbGpPWpGaD
